Sveriges mest populära poddar
Docs Who Lift
Hälsa och motionMedicin

Zepbound - Tirzepatide for obesity approval

23 min•10 november 2023

Drs. Karl and Spencer discuss how tirzepatide is now approved for obesity.

Learn:

  1. When will it be available
  2. How much will is cost
  3. Any differences compared to Mounjaro
  4. Surmount 3 trial



Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Fler avsnitt av Docs Who Lift

Visa alla avsnitt av Docs Who Lift
Is Your Obesity Genetic? Food Noise and Bardet-Biedl Syndrome Explained
•40 min
PCOS Renamed to PMOS? Here's Why and What Changes for You
•37 min
Are Peptides the New Snake Oil? What the Actual Science Says With Barbell Medicine
•57 min
Retatrutide Phase 3 Results: What the Data Actually Means
•45 min
GLP-1 Maintenance: What Happens When You Lower Your Dose, Switch Medications, or Stop Entirely
•40 min
Are GLP-1 Medicines Shredding Your Bones? Here Is What the Actual Evidence Says With Dr. Susan Brian
•32 min
Heavy Metal Toxicity: Separating Real Risks From Influencer Scams | Dr. Eryn Russo
•53 min
GLP-1 Genetics: Predicting Weight Loss and Side Effects With 23andMe's Dr. Adam Auton
•25 min
Do GLP-1 Medicines Actually Cause Muscle Loss? New Research With Dr. Henning Langer
•36 min
How Often Should You Really Lift Weights? Feat. Dr. Stuart Phillips
•52 min

Docs Who Lift med Docs Who Lift finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.